SLC13A4 Might Serve As a Prognostic Biomarker and Be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma

Overview

Journal Pathol Oncol Res

Specialty Oncology

Date 2021 Nov 29

PMID 34840533

Citations 2

Authors

Meng-Ling Yang

Jia-Hua Zhang

Sheng Li

Rui Zhu

Li Wang

Affiliations

Soon will be listed here.

Abstract

SLC13A4 is a sodium sulfate co-transporter, which is expressed in brains, placentas, thymes and other tissues, plays an essential role in maintaining the metabolic balance of sulfate . The TCGA database shows that it is differentially expressed in a variety of tumors, but its prognostic value in tumors has not been clarified. TCGA, Oncomine and Timer databases were used to analyze SLC13A4 mRNA expression in cancer tissues and normal tissues, and its correlation with clinical prognosis in head and neck tumor. The CIBERSORT database was used to analyze the correlation between SLC13A4 expression and the infiltration of immune cells. SLC13A4 enrichment analysis was carried out by GSEA. SLC13A4 mRNA levels were significantly lower in head and neck tumors than in paracancer tissues. SLC13A4 expression in Head and neck squamous cell carcinoma (HNSCC) was closely related to tumor pathological grade and clinical stage. Decreased SLC13A4 expression was associated with poor overall survival (OS), progression free survival (PFS), disease specific survival (DSS) and recurrence free survival (RFS) in HNSCC patients. The expression of SLC13A4 was negatively correlated with Monocytes, M1 macrophages, M2 macrophages, resting CD4+ memory T cells, resting NK cells and activated NK cells, but positively correlated with neutrophils, plasma cells, T follicular helper cells, gamma delta T cells, regulatory T cells and naive B cells. In addition, the genes in SLC13A4 low-expression group were mainly concentrated in immunity-related activities, viral diseases, typical tumor pathways and metabolism. The SLC13A4 high expression group was mainly enriched in metabolic pathways. These suggest that SLC13A4 may be a potential prognostic biomarker in HNSC and correlated with immune infiltrates.

Citing Articles

Exploring tumor-normal cross-talk with TranNet: Role of the environment in tumor progression.

Amgalan B, Day C, Przytycka T PLoS Comput Biol. 2023; 19(9):e1011472.

PMID: 37721939 PMC: 10538798. DOI: 10.1371/journal.pcbi.1011472.

Exploring tumor-normal cross-talk with TranNet: role of the environment in tumor progression.

Amgalan B, Day C, Przytycka T bioRxiv. 2023; .

PMID: 36945455 PMC: 10028821. DOI: 10.1101/2023.02.24.529899.

References

Chwatko G, Forma E, Wilkosz J, Glowacki R, Jozwiak P, Rozanski W . Thiosulfate in urine as a facilitator in the diagnosis of prostate cancer for patients with prostate-specific antigen less or equal 10 ng/mL. Clin Chem Lab Med. 2013; 51(9):1825-31. DOI: 10.1515/cclm-2013-0069. View

Baskar R, Bian J . Hydrogen sulfide gas has cell growth regulatory role. Eur J Pharmacol. 2011; 656(1-3):5-9. DOI: 10.1016/j.ejphar.2011.01.052. View

Hastbacka J, de la Chapelle A, Mahtani M, Clines G, Daly M, Hamilton B . The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell. 1994; 78(6):1073-87. DOI: 10.1016/0092-8674(94)90281-x. View

Liang B, Tao Y, Wang T . Profiles of immune cell infiltration in head and neck squamous carcinoma. Biosci Rep. 2020; 40(2). PMC: 7042147. DOI: 10.1042/BSR20192724. View

Cao Q, Zhang L, Yang G, Xu C, Wang R . Butyrate-stimulated H2S production in colon cancer cells. Antioxid Redox Signal. 2009; 12(9):1101-9. DOI: 10.1089/ars.2009.2915. View

Dawson P . Role of sulphate in development. Reproduction. 2013; 146(3):R81-9. DOI: 10.1530/REP-13-0056. View

Bergeron M, Clemencon B, Hediger M, Markovich D . SLC13 family of Na⁺-coupled di- and tri-carboxylate/sulfate transporters. Mol Aspects Med. 2013; 34(2-3):299-312. DOI: 10.1016/j.mam.2012.12.001. View

Cai W, Wang M, Ju L, Wang C, Zhu Y . Hydrogen sulfide induces human colon cancer cell proliferation: role of Akt, ERK and p21. Cell Biol Int. 2010; 34(6):565-72. DOI: 10.1042/CBI20090368. View

Ferris R, Blumenschein Jr G, Fayette J, Guigay J, Colevas A, Licitra L . Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression. Oral Oncol. 2018; 81:45-51. PMC: 6563923. DOI: 10.1016/j.oraloncology.2018.04.008. View

10.

Rakoczy J, Zhang Z, Bowling F, Dawson P, Simmons D . Loss of the sulfate transporter Slc13a4 in placenta causes severe fetal abnormalities and death in mice. Cell Res. 2015; 25(11):1273-6. PMC: 4650418. DOI: 10.1038/cr.2015.100. View

11.

Miyauchi S, Srinivas S, Fei Y, Gopal E, Umapathy N, Wang H . Functional characteristics of NaS2, a placenta-specific Na+-coupled transporter for sulfate and oxyanions of the micronutrients selenium and chromium. Placenta. 2005; 27(6-7):550-9. DOI: 10.1016/j.placenta.2005.05.004. View

12.

Troiano G, Rubini C, Togni L, Caponio V, Zhurakivska K, Santarelli A . The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis. Cancer Med. 2020; 9(22):8333-8344. PMC: 7666743. DOI: 10.1002/cam4.3440. View

13.

Miller K, Fidler-Benaoudia M, Keegan T, Hipp H, Jemal A, Siegel R . Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 2020; 70(6):443-459. DOI: 10.3322/caac.21637. View

14.

Demydchuk M, Hill C, Zhou A, Bunkoczi G, Stein P, Marchesan D . Insights into Hunter syndrome from the structure of iduronate-2-sulfatase. Nat Commun. 2017; 8:15786. PMC: 5472762. DOI: 10.1038/ncomms15786. View

15.

Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

16.

Wang Z, Jensen M, Zenklusen J . A Practical Guide to The Cancer Genome Atlas (TCGA). Methods Mol Biol. 2016; 1418:111-41. DOI: 10.1007/978-1-4939-3578-9_6. View

17.

Solomon B, Young R, Rischin D . Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments. Semin Cancer Biol. 2018; 52(Pt 2):228-240. DOI: 10.1016/j.semcancer.2018.01.008. View

18.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

19.

Jiang H, Ni H, Zhang P, Guo X, Wu M, Shen H . PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity. Oncoimmunology. 2021; 10(1):1943180. PMC: 8237984. DOI: 10.1080/2162402X.2021.1943180. View

20.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View